Melissa Rodríguez
Brighton Hospital(US)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Histone Deacetylase Inhibitors Research, HIV/AIDS Research and Interventions, Acute Myeloid Leukemia Research
Most-Cited Works
- → Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways(2008)353 cited
- → Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells(2014)191 cited
- → Lgr4 is a key regulator of prostate development and prostate stem cell differentiation(2013)66 cited
- → Haploinsufficiency in the Prometastasis Kiss1 Receptor Gpr54 Delays Breast Tumor Initiation, Progression, and Lung Metastasis(2011)47 cited
- → ClaPD (Clarithromycin/[Biaxin®], Pomalidomide, Dexamethasone) Therapy in Relapsed or Refractory Multiple Myeloma(2011)42 cited
- → Synthesis of a Fluorescently Labeled 68Ga-DOTA-TOC Analog for Somatostatin Receptor Targeting(2017)36 cited
- → Leucine-rich repeat–containing G protein–coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial–mesenchymal transition(2017)33 cited
- → A Phase I/Ib Trial of PD 0332991 (Palbociclib) and T-DM1 in HER2-Positive Advanced Breast Cancer After Trastuzumab and Taxane Therapy(2021)21 cited
- → A Modular Dual-Labeling Scaffold That Retains Agonistic Properties for Somatostatin Receptor Targeting(2017)14 cited
- → Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma(2014)11 cited